Publications
Return to Publications Listing
C-MAP™ Canadian Drug Benefit Plans Reference Guide
Order Form | C-MAP™ Canadian Drug Benefit Plans Reference Guide
Frequently Asked Questions
- What are the advantages of the C-MAP™ Canadian Drug Benefit Plans Reference Guide over other publications?
- What are the benefits of this resource since most of the information provided is publicly available?
- How popular is C-MAP™ Canadian Drug Benefit Plans Reference Guide?
- How current is the information provided?
- How many subscribers do you have?
- How often are the updates sent?
- What key contact names do you provide?
- Is the publication available online?
- Is there a French version available?
- What is the cost of C-MAP™ Canadian Drug Benefit Plans Reference Guide?
- How soon would I receive the publication after ordering?
If you have any additional questions concerning the Canadian Drug Benefit Plans Reference Guide, please e-mail us at c-map@pdci.ca or call Jayne Lamb at (613) 742-8225 x21.
Frequently Asked Questions
- What are the advantages of the C-MAP™ Canadian Drug Benefit Plans Reference Guide over other publications?
Our publication is designed to offer more detailed information than any other resource. Some of the content is similar although we provide more information on description of drug plans, drug expenditure data, special drug programs, special authorization and listing processes, reimbursement policies, provincial reporting structure, federal/provincial/territorial initiatives, the Common Drug Review, the PMPRB, etc.
- What are the benefits of this resource since most of the information provided is publicly available?
This resource is compiled in a 2-volume reference format, such that the information on each drug plan is presented in a consistent manner. This saves time in the retrieval of information. Some of the information, although publicly available, is not readily available, and requires direct communication with the drug program manager - a time consuming task.
- How popular is C-MAP™ Canadian Drug Benefit Plans Reference Guide?
Most major pharmaceutical companies subscribe to this valuable resource, and it has been very well received. We are in our ninth year of printing with a very high renewal rate. We have expanded the content to reflect the needs of subscribers based on their feedback.
- How current is the information provided?
We have specific staff members who are assigned to remain aware of the changing aspects on the Canadian Drug Benefit Plans scene. We are dedicated to being the leading source for up-to-date information in this area.
- How many subscribers do you have?
Most major pharmaceutical companies subscribe to C-MAP™ Canadian Drug Benefit Plans Reference Guide. We are now listed in the Scrip Catalogue and marketed through Urch Publishing identifying us as a valuable resource internationally.
- How often are the updates sent?
Notification of any major changes will be sent by email on an ongoing basis. In addition, thorough updates will be sent quarterly via email to ensure that all changes are captured. We also offer a password-protected online version of C-MAP™ Canadian Drug Benefit Plans Reference Guide, which is kept current and can be accessed at any time by subscribers using a password.
- What key contact names do you provide?
We provide the key contacts for each provincial/federal drug program as well as the names and affiliations of advisory committee members. Also included are the reporting structures for each province with key contacts at different levels.
- Is the publication available online?
Yes, a password-protected online version of C-MAP™ Canadian Drug Benefit Plans Reference Guide is now available to subscribers. The online version of C-MAP™ Canadian Drug Benefit Plans Reference Guide will be kept current for subscribers to access at their convenience.
- Is there a French version available?
A French version of the entire resource is not available yet. We are assessing whether there is sufficient demand for a French version to offset the costs of translation.
- What is the cost of C-MAP™ Canadian Drug Benefit Plans Reference Guide?
This publication is competitively priced at $5950.00 CDN for an annual subscription and offers great value for the cost. The 2012 Edition includes company-wide access to the online version, new sections, and regular updates. Additional copies are offered at $1950 CDN per copy, which is a significant reduction in price.
- How soon would I receive the publication after ordering?
Any orders for C-MAP™ Canadian Drug Benefit Plans Reference Guide are sent the next day by courier.
